CD274 and lung cancer: In an in vivo trial, triple combination therapy, i.e., radiation combined with PD-L1 monoclonal antibody and anlotinib, was used to improve the tumor microenvironment and to counteract the immunosuppressive effects of radiation on the tumor microenvironment in Lewis lung cancer mice.